Literature DB >> 24620845

Holter electrocardiography findings and P-wave dispersion in pediatric patients with transcatheter closure of atrial septal defects.

Isa Ozyilmaz1, Sinem Ozyilmaz, Hasan Tahsin Tola, Murat Saygi, Neslihan Kiplapinar, Cansaran Tanıdır, Yakup Ergul, Alper Guzeltas, Ender Odemis.   

Abstract

BACKGROUND: This study aimed to determine the frequency of postintervention arrhythmia and factors associated with the development of arrhythmia, including the correlation between arrhythmia and P-wave dispersion, and the effects of the latter on transcatheter closure of atrial septal defects (ASDs).
METHODS: Holter ECG recordings were performed before and after the intervention and 6 and 12 months later in 47 of the 59 patients who had undergone transcatheter ASD closure and once in the healthy control subjects.
RESULTS: A statistically significant correlation was identified between the patients' arrhythmia grade according to Lown's system and each of the following: the number of defects, the size of the atrioventricular valve rim, the presence of an atrial septal aneurysm.
CONCLUSION: The frequency of arrhythmia increases after transcatheter ASD closure, gradually decreases within the next year, and is most frequently of a benign nature. Lown's arrhythmia grading of patients occluded with either the Amplatzer septal occluder (ASO) or the Cardio-O-Fix septal occluder (CSO) were compared, and the arrhythmia frequency was higher with the latter. One day after the intervention, the P maximum (Pmax ) and the P dispersion(Pdis ) values were not increased but in fact slightly reduced in patients occluded with either ASO or CSO. An improvement in the electrical system resulting from early anatomical and mechanical healing following transcatheter ASD occlusion may explain the reduction in the Pmax and Pdis values. ©2013, Wiley Periodicals, Inc.

Entities:  

Keywords:  Holter ECG; atrial septal defect; children; p-wave dispersion; transcatheter closure

Mesh:

Year:  2013        PMID: 24620845      PMCID: PMC6932328          DOI: 10.1111/anec.12104

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  33 in total

1.  Cardiac dysrhythmias after transcatheter closure of ASD with Amplatzer device.

Authors:  Alpay Celiker; Süheyla Ozkutlu; Cemşit Karakurt; Tevfik Karagöz
Journal:  Turk J Pediatr       Date:  2005 Oct-Dec       Impact factor: 0.552

2.  Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.

Authors:  Christian Spies; Abha Khandelwal; Ines Timmermanns; Rainer Schräder
Journal:  Am J Cardiol       Date:  2008-07-17       Impact factor: 2.778

3.  Analysis of maximum P-wave duration and dispersion after percutaneous closure of atrial septal defects: comparison of two septal occluders.

Authors:  Feyza Ayşenur Paç; Sevket Balli; Serkan Topaloğlu; Ibrahim Ece; Mehmet Burhan Oflaz
Journal:  Anadolu Kardiyol Derg       Date:  2012-03-02

4.  Clinical and electrocardiographic predictors of recurrent atrial fibrillation.

Authors:  P E Dilaveris; E J Gialafos; G K Andrikopoulos; D J Richter; V Papanikolaou; K Poralis; J E Gialafos
Journal:  Pacing Clin Electrophysiol       Date:  2000-03       Impact factor: 1.976

5.  Early and late complications associated with transcatheter occlusion of secundum atrial septal defect.

Authors:  Massimo Chessa; Mario Carminati; Gianfranco Butera; Roberta Margherita Bini; Manuela Drago; Luca Rosti; Alessandro Giamberti; Giuseppe Pomè; Eduardo Bossone; Alessandro Frigiola
Journal:  J Am Coll Cardiol       Date:  2002-03-20       Impact factor: 24.094

6.  Symptomatic tachy- and bradyarrhythmias after transcatheter closure of interatrial communications with Amplatzer devices.

Authors:  Małgorzata Szkutnik; Anna Lenarczyk; Jacek Kusa; Jacek Białkowski
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

7.  Reversible atrioventricular block associated with closure of atrial septal defects using the Amplatzer device.

Authors:  Kenji Suda; Marie-Josée Raboisson; Eric Piette; Nagib S Dahdah; Joaquim Miró
Journal:  J Am Coll Cardiol       Date:  2004-05-05       Impact factor: 24.094

8.  Symptomatic atrial arrhythmias and transcatheter closure of atrial septal defects in adult patients.

Authors:  C K Silversides; S C Siu; P R McLaughlin; K L Haberer; G D Webb; L Benson; L Harris
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

9.  Cardiac dysrhythmias in pediatric patients before and 1 year after transcatheter closure of atrial septal defects using the amplatzer septal occluder.

Authors:  G Hessling; S Hyca; K Brockmeier; H E Ulmer
Journal:  Pediatr Cardiol       Date:  2003-01-15       Impact factor: 1.655

10.  Progression to late complete atrioventricular block following amplatzer device closure of atrial septal defect in a child.

Authors:  Rodrigo A Nehgme; Amber R Huddleston; John P Cheatham
Journal:  Pediatr Cardiol       Date:  2008-11-11       Impact factor: 1.655

View more
  4 in total

1.  Comparison of primary repair and patch plasty procedure on the P wave in adult atrial septal defect closure.

Authors:  Alper Ucak; Veysel Temizkan; Murat Ugur; Ahmet Erturk Yedekci; Omer Uz; Arif Selcuk; Ahmet Turan Yilmaz
Journal:  Cardiovasc J Afr       Date:  2016-05-04       Impact factor: 1.167

2.  Author's Reply.

Authors:  İsa Özyılmaz; Sinem Özyılmaz; Yakup Ergül; Alper Güzeltaş
Journal:  Anatol J Cardiol       Date:  2015-10       Impact factor: 1.596

3.  Heart rate variability improvement in children using transcatheter atrial septal defect closure.

Authors:  İsa Özyılmaz; Yakup Ergül; Hasan Tahsin Tola; Murat Saygı; Erkut Öztürk; İbrahim Cansaran Tanıdır; Öyku Tosun; Sinem Özyılmaz; Mehmet Gül; Alper Güzeltaş; Ender Ödemiş; İhsan Bakır
Journal:  Anatol J Cardiol       Date:  2015-03-04       Impact factor: 1.596

4.  Immediate and short term effects of percutaneous atrial septal defect device closure on cardiac electrical remodeling in children.

Authors:  Alaa Mahmoud Roushdy; Hebatalla Attia; Heba Nossir
Journal:  Egypt Heart J       Date:  2018-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.